Discovery of a novel, potent and selective human β3-adrenergic receptor agonist

This publication has 14 references indexed in Scilit:

• Functional and Molecular Characterization of β-Adrenoceptors in the Internal Anal Sphincter
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• Novel and potent human and rat β3-Adrenergic receptor agonists containing substituted 3-indolylalkylamines
  Bioorganic & Medicinal Chemistry Letters, 2003
• Orally Bioavailable β3-Adrenergic Receptor Agonists as Potential Therapeutic Agents for Obesityand Type-II Diabetes
  Progress in Medicinal Chemistry, 2003
• Beta3 -Adrenoceptor Agonists as Anti-diabetic and Anti-obesity Drugs in Humans
  Current Pharmaceutical Design, 2001
• Development of ?3-adrenoceptor agonists as antiobesity and antidiabetes drugs in humans: Current status and future prospects
  Drug Development Research, 2000
• Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
  Diabetes, 1998
• In vitro inhibition of human colonic motility with SR 59119A and SR 59104A: evidence of a β3-adrenoceptor-mediated effect
  European Journal of Pharmacology, 1998
• STRUCTURE AND FUNCTION OF THE β₃-ADRENERGIC RECEPTOR
  Annual Review of Pharmacology and Toxicology, 1997
• Molecular Characterization of the Human β ₃ -Adrenergic Receptor
  Science, 1989
• Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs
  Nature, 1984